United States

Biotechnology firm Cytos is to link up with US pharmaceutical giant Pfizer in the development of vaccines for a number of human diseases, the Swiss firm announced on August 15 2008.... 2008-08-21

Prestwick Pharmaceuticals has received US FDA orphan drug approval for Xenazine (tetrabenazine). Xenazine will be the first drug available in the US for the treatment of Huntington's... 2008-08-18

Sales from outside Western Europe continued to drive French firm Ipsen's growth in H108. Underlying sales -calculated at a constant exchange rate and excluding sales for Ginkor Fort... 2008-08-13

As a strategy, outsourcing forms a key part of US-based Eli Lilly's drive to streamline its R&D processes. Over the past few years, the company, like many multinational drugmakers,... 2008-08-08

Gilead Sciences' Viread (tenofovir) and Truvada (emtricitabine) will be tested in single and combination doses in about 16,000 uninfected healthy people for pre-exposure prophylaxis... 2008-08-07

The US FDA has released its list of approved seasonal influenza vaccines for the 2008-2009 season. A total of six vaccines have been approved, which protect against new strains of... 2008-08-07

The US government's 'pilot project' for universal healthcare - the Massachusetts Mandatory Health Insurance Programme - has been dealt a blow in an open letter from more than 250... 2008-08-06

US pharmaceutical giant Pfizer is looking to build a new R&D centre in Central and Eastern Europe (CEE), with Hungary one of the key contenders. According to the head of Pfizer's... 2008-08-05

The US FDA has issued a "not-approvable" letter for Schering-Plough's Bridion (sugammadex), a drug used to reverse the effects of anesthesia.

US-based Vanguard Pharmaceutical has signed a contract to sell the generics portfolio of India's Arbro Pharmaceutical in Latin America and the Caribbean. The deal gives Vanguard exclusive... 2008-08-04